Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLRZ Polyrizon Ltd.

休市中 09-11 16:00:00 EDT

11.03

-0.20

-1.78%

盘后11.03

+0.000.00%

19:30 EDT

最高11.36	最低10.50	成交量7.66万
今开11.19	昨收11.23	日振幅7.66%
总市值2,650万	流通市值2,322万	总股本240.21万
成交额84.21万	换手率3.64%	流通股本210.51万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":11.03,"timestamp":1789156800000,"preClose":11.23,"halted":0,"volume":76584,"hourTrading":{"tag":"盘后","latestPrice":11.03,"preClose":11.03,"latestTime":"19:30 EDT","volume":8,"amount":88.3378,"timestamp":1789169407303,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01780943900267151,"floatShares":2105100,"shares":2402100,"eps":-4.901672,"marketStatus":"休市中","change":-0.2,"latestTime":"09-11 16:00:00 EDT","open":11.19,"high":11.355,"low":10.495,"amount":842134.9719840001,"amplitude":0.076581,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.901672,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":11.23,"preHourTrading":{"tag":"盘前","latestPrice":11.25,"preClose":11.23,"latestTime":"08:36 EDT","volume":15,"amount":166.24999499999998,"timestamp":1789130164513,"change":0.02,"changeRate":0.001781,"amplitude":0.022262},"postHourTrading":{"tag":"盘后","latestPrice":11.03,"preClose":11.03,"latestTime":"19:30 EDT","volume":8,"amount":88.3378,"timestamp":1789169407303,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6848129335637719},"requestUrl":"/m/hq/s/PLRZ","defaultTab":"news","newsList":[{"id":"1132297876","title":"Polyrizon完成Nasarix™研究临床中心网络建设，向患者入组迈进","url":"https://stock-news.laohu8.com/highlight/detail?id=1132297876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132297876?lang=zh_cn&edition=full","pubTime":"2026-08-20 21:30","pubTimestamp":1787232625,"startTime":"0","endTime":"0","summary":"Polyrizon已成功构建Nasarix™研究的临床中心网络，并正稳步推进至患者入组阶段。这一里程碑式的进展，标志着该公司在鼻腔给药技术领域的研究又向前迈出了关键一步。随着临床站点网络的全面落成，Polyrizon现已具备启动患者招募工作的充分条件，为后续试验的顺利开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105819292","title":"Polyrizon公布Nasarix™生物相容性项目成功结果，支持向首次人体临床试验迈进","url":"https://stock-news.laohu8.com/highlight/detail?id=1105819292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105819292?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:37","pubTimestamp":1782992238,"startTime":"0","endTime":"0","summary":"Polyrizon公司宣布，其Nasarix™生物相容性项目已取得积极成果。这一关键进展有力地支持了该项目向首次人体临床试验阶段推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174404710","title":"Polyrizon与Arrow Aviation签署函件协议 将MOU下的排他期及初期谈判期延长至6月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=1174404710","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174404710?lang=zh_cn&edition=full","pubTime":"2026-06-06 04:25","pubTimestamp":1780691121,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 与 Arrow Aviation 已正式签署一份函件协议。根据该协议，双方此前在谅解备忘录（MOU）框架下约定的排他性谈判期及初期谈判阶段，将一并延长至今年6月30日。此举旨在为双方就潜在合作事宜提供更充分的协商时间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162623204","title":"Polyrizon Ltd. 签署协议进行普通股及预融资认股权证的注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1162623204","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162623204?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:02","pubTimestamp":1775563325,"startTime":"0","endTime":"0","summary":"生物技术公司Polyrizon Ltd. (PLRZ) 近日宣布，该公司已达成最终协议，将通过注册直接发行的方式，向机构投资者发售其普通股及预融资认股权证。\n此次发行旨在为公司的重要研发项目及一般营运资金需求筹集资金。根据市场惯例，此次发行的完成仍需满足特定的交割条件。\n通过这种融资方式，Polyrizon Ltd. 期望能加速其在研管线的进展，并进一步巩固其财务状况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198342122","title":"Polyrizon计划收购先进eVTOL无人机开发商Colugo至多20%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1198342122","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198342122?lang=zh_cn&edition=full","pubTime":"2026-03-24 20:48","pubTimestamp":1774356518,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 已宣布一项战略投资计划，拟收购Colugo公司的部分股权。Colugo是一家专注于研发先进电动垂直起降（eVTOL）无人机的企业，其产品主要应用于国防及城市空中交通领域。根据计划，Polyrizon此次收购的股权比例最高可达20%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177669566","title":"Polyrizon携手全球领先临床前CRO，加速推进临床开发项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1177669566","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177669566?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:27","pubTimestamp":1773750433,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. (PLRZ) 已与一家全球顶尖的临床前合同研究组织（CRO）正式签署合作协议，此举是其整体临床开发计划中的关键一步。\n该合作旨在利用该CRO在临床前研究领域的专业能力和全球资源，以推进Polyrizon研发管线的进展。协议的签署标志着公司向临床阶段迈出了实质性的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618807421","title":"Polyrizon Ltd.盘中异动 大幅下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618807421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618807421?lang=zh_cn&edition=full","pubTime":"2026-03-12 03:40","pubTimestamp":1773258044,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日03时40分，Polyrizon Ltd.股票出现波动，股价快速下挫5.17%。截至发稿，该股报12.29美元/股，成交量7752股，换手率0.74%，振幅5.48%。Polyrizon Ltd.股票所在的生物技术行业中，整体跌幅为1.05%。Polyrizon Ltd.公司简介：Polyrizon Ltd是一家处于临床开发阶段的生物技术公司，专门开发鼻用凝胶，以提供抵御各种病毒的预防性治疗，包括某些 COVID-19 变种，这些变种也被认为比病毒的原始毒株引起更多的感染并传播得更快，流感、过敏原和其他毒素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312034044a6b8ccb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312034044a6b8ccb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146277893","title":"Polyrizon宣布与Eurofins CDMO Amatsiaquitaine S.a.s合作生产cGMP临床实验材料，用于计划中的美国临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1146277893","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146277893?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:55","pubTimestamp":1773143714,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 已正式宣布，其将与Eurofins CDMO Amatsiaquitaine S.a.s合作，启动符合药品生产质量管理规范（GMP）的临床实验材料（CTM）生产工作。此项生产旨在为该公司计划在美国开展的临床研究提供所需材料。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polyrizon-biotech.com","stockEarnings":[{"period":"1week","weight":-0.0187},{"period":"1month","weight":0.1348},{"period":"3month","weight":-0.009},{"period":"6month","weight":-0.2287},{"period":"1year","weight":0.8806},{"period":"ytd","weight":0.2992}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Polyrizon Ltd.于2005年1月在以色列注册成立。该公司是一家处于发展阶段的生物技术公司，专门开发以鼻喷雾剂形式交付的创新医疗器械水凝胶，该水凝胶在鼻腔内形成一层薄薄的基于水凝胶的防护屏障，可以防止病毒和过敏原接触鼻上皮组织。该公司的C&C水凝胶技术由天然存在的构建块的混合物组成，以鼻喷雾剂的形式提供，并可用作“生物面具”，在鼻腔内有一层薄薄的防护屏障。该公司正在进一步开发其专有的C&C水凝胶技术的某些方面，例如生物粘附性和在鼻腔沉积部位的延长保留时间，以用于鼻内给药。该公司将其专注于API鼻腔给药的独立平台技术称为T&T。","exchange":"NASDAQ","name":"Polyrizon Ltd.","nameEN":"Polyrizon Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Polyrizon Ltd.(PLRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Polyrizon Ltd.,PLRZ,Polyrizon Ltd.股票,Polyrizon Ltd.股票老虎,Polyrizon Ltd.股票老虎国际,Polyrizon Ltd.行情,Polyrizon Ltd.股票行情,Polyrizon Ltd.股价,Polyrizon Ltd.股市,Polyrizon Ltd.股票价格,Polyrizon Ltd.股票交易,Polyrizon Ltd.股票购买,Polyrizon Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Polyrizon Ltd.(PLRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}